PofoliaPofolia ile paylaşıldı

Cardiovascular Diabetology· 2018Q1· Derleme

Tip 2 Diyabet Hastalarında Kardiyovasküler Hastalık Yaygınlığı: Küresel Bilimsel Kanıtların Sistematik Literatür Taraması (2007–2017)

Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017

Thomas R. Einarson, Annabel Acs, Craig Ludwig, Ulrik Haagen Panton

Kısa özet

Tip 2 diyabeti (T2DM) olan 4,5 milyonun üzerindeki hastayı kapsayan sistematik bir derlemeye göre, küresel olarak Tip 2 diyabet hastalarının %32,2'sinde kardiyovasküler hastalık (KVH) bulunmaktadır ve en yaygın türler koroner arter hastalığı ve felçtir.

Yapay zekâ ile başlık ve abstract'tan üretildi; tam metin okunmaz.

Ana noktalar

  • Tip 2 diyabeti (T2DM) olan bireylerin küresel olarak %32,2'sinde kardiyovasküler hastalık (KVH) bulunmaktadır.
  • T2DM hastalarında en yaygın KVH türleri koroner arter hastalığı (%21,2) ve aterosklerozdur (%29,1).
  • KVH, T2DM popülasyonundaki tüm ölümlerin %50,3'ünü oluşturmaktadır.
  • Derleme, 4.549.481 T2DM hastasını temsil eden 57 makaleden elde edilen verileri analiz etmiştir.

Yapay zekâ ile başlık ve abstract'tan üretildi; tam metin okunmaz.

Özet (abstract)

BACKGROUND: Cardiovascular disease (CVD) is a common comorbidity in type 2 diabetes (T2DM). CVD's prevalence has been growing over time. PURPOSE: To estimate the current prevalence of CVD among adults with T2DM by reviewing literature published within the last 10 years (2007-March 2017). METHODS: We searched Medline, Embase, and proceedings of major scientific meetings for original research documenting the prevalence of CVD in T2DM. CVD included stroke, myocardial infarction, angina pectoris, heart failure, ischemic heart disease, cardiovascular disease, coronary heart disease, atherosclerosis, and cardiovascular death. No restrictions were placed on country of origin or publication language. Two reviewers independently searched for articles and extracted data, adjudicating results through consensus. Data were summarized descriptively. Risk of bias was examined by applying the STROBE checklist. RESULTS: We analyzed data from 57 articles with 4,549,481 persons having T2DM. Europe produced the most articles (46%), followed by the Western Pacific/China (21%), and North America (13%). Overall in 4,549,481 persons with T2DM, 52.0% were male, 47.0% were obese, aged 63.6 ± 6.9 years old, with T2DM duration of 10.4 ± 3.7 years. CVD affected 32.2% overall (53 studies, N = 4,289,140); 29.1% had atherosclerosis (4 studies, N = 1153), 21.2% had coronary heart disease (42 articles, N = 3,833,200), 14.9% heart failure (14 studies, N = 601,154), 14.6% angina (4 studies, N = 354,743), 10.0% myocardial infarction (13 studies, N = 3,518,833) and 7.6% stroke (39 studies, N = 3,901,505). CVD was the cause of death in 9.9% of T2DM patients (representing 50.3% of all deaths). Risk of bias was low; 80 ± 12% of STROBE checklist items were adequately addressed. CONCLUSIONS: Globally, overall CVD affects approximately 32.2% of all persons with T2DM. CVD is a major cause of mortality among people with T2DM, accounting for approximately half of all deaths over the study period. Coronary artery disease and stroke were the major contributors.

Yazarların özeti; kaynağından alınmıştır. Cardiovascular Diabetology, 2018 · DOI ↗

ÇıkarımlarPremium
Makaleye SorÜcretsiz hesapla

Ücretsiz hesapla devam et

Makaleye Sor ile bu makaleye günde 3 soru ücretsiz; makaleyi kaydet, kaynakçasını al, ilgi alanına göre her gün yeni özetler. Çıkarımlar Premium.

Web'de ücretsiz devam et

Google ya da Apple hesabınla giriş; kart istemez. Bu makaleye geri dönersin.

Telefonda:

Alan: Endokrinoloji, Diyabet ve Metabolizma

Endocrinology, Diabetes and MetabolismMedicine